🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is an open-label, non-randomized, multi-cohort, multi-center Phase Ia/...
Status
Terminated
Location
Beijing Cancer Hospital
Start Date
2023-07-27
Trial ID
NCT06032936
Treatments Being Tested
This is a Phase 1 study of BBP-398, a SHP2 inhibitor, in combination with n...
Status
Terminated
Location
Highlands Oncology
Start Date
2022-10-20
Trial ID
NCT05375084
Treatments Being Tested
This is a Phase 1 study of BBP-398, a SHP2 inhibitor, in combination with s...
Status
Terminated
Location
Cancer Research SA
Start Date
2022-07-06
Trial ID
NCT05480865
A first-in-human study to evaluate the safety, tolerability and maximum tol...
Status
Terminated
Location
University of Alabama at Birmingham
Start Date
2020-11-12
Trial ID
NCT04528836
Treatments Being Tested
The purpose of this study is to find a safe, tolerable, and efficacious dos...
Status
Terminated
Location
Local Institution - 0047
Start Date
2023-11-09
Trial ID
NCT06024174
Treatments Being Tested
This is an open label, dose escalation and expansion, two-part Phase I stud...
Status
Terminated
Location
Sun Yat-sen University Cancer Center
Start Date
2022-10-18
Trial ID
NCT05621525
Treatments Being Tested